D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele - PubMed (original) (raw)
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele
J Thompson et al. Pharmacogenetics. 1997 Dec.
Abstract
The relationship between a dopamine D2 receptor genetic polymorphism at the Taq1 A locus and the level of D2 receptor binding was investigated in normal, middle aged to elderly subjects with no psychiatric or neurological disorders. D2 receptor binding was measured by autoradiography in the caudate, putamen and nucleus accumbens, using the specific D2 receptor ligand [3H]-raclopride. In a sample of 44 individuals, only one was homozygous for the A1 allele, 25 were homozygous for A2 and 18 were heterozygotes. The presence of one or two A1 alleles was associated with reduced D2 receptor binding in all areas of the striatum, reaching statistical significance in the ventral caudate and putamen (p = 0.01 and p = 0.044, respectively). This reduction was more marked in males than females, particularly in the putamen. A genetic predisposition to lower D2 receptor expression may increase susceptibility to neuroleptic medication or clinical symptoms that are associated with diseases involving dopaminergic pathology.
Similar articles
- The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients.
Suzuki A, Mihara K, Kondo T, Tanaka O, Nagashima U, Otani K, Kaneko S. Suzuki A, et al. Pharmacogenetics. 2000 Jun;10(4):335-41. doi: 10.1097/00008571-200006000-00007. Pharmacogenetics. 2000. PMID: 10862524 - Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients.
Suzuki A, Kondo T, Mihara K, Furukori H, Nagashima U, Ono S, Otani K, Kaneko S. Suzuki A, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2000 Oct;24(7):1105-13. doi: 10.1016/s0278-5846(00)00132-9. Prog Neuropsychopharmacol Biol Psychiatry. 2000. PMID: 11131175 - Dopamine DRD2 Taq I polymorphism associates with caudate nucleus volume and cognitive performance in memory impaired subjects.
Bartrés-Faz D, Junqué C, Serra-Grabulosa JM, López-Alomar A, Moya A, Bargalló N, Mercader JM, Moral P, Clemente IC. Bartrés-Faz D, et al. Neuroreport. 2002 Jul 2;13(9):1121-5. doi: 10.1097/00001756-200207020-00010. Neuroreport. 2002. PMID: 12151753 - D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene.
Laruelle M, Gelernter J, Innis RB. Laruelle M, et al. Mol Psychiatry. 1998 May;3(3):261-5. doi: 10.1038/sj.mp.4000343. Mol Psychiatry. 1998. PMID: 9672902 - Polymorphisms of the D2 dopamine receptor gene and alcoholism and other substance use disorders.
Noble EP. Noble EP. Alcohol Alcohol Suppl. 1994;2:35-43. Alcohol Alcohol Suppl. 1994. PMID: 8974314 Review.
Cited by
- Dopamine Dysregulation in Reward and Autism Spectrum Disorder.
Blum K, Bowirrat A, Sunder K, Thanos PK, Hanna C, Gold MS, Dennen CA, Elman I, Murphy KT, Makale MT. Blum K, et al. Brain Sci. 2024 Jul 22;14(7):733. doi: 10.3390/brainsci14070733. Brain Sci. 2024. PMID: 39061473 Free PMC article. Review. - Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences.
Blum K, Bowirrat A, Baron D, Elman I, Makale MT, Cadet JL, Thanos PK, Hanna C, Ahmed R, Gondre-Lewis MC, Dennen CA, Braverman ER, Soni D, Carney P, Khalsa J, Modestino EJ, Barh D, Bagchi D, Badgaiyan RD, McLaughlin T, Cortese R, Ceccanti M, Murphy KT, Gupta A, Makale MT, Sunder K, Gold MS. Blum K, et al. Gene Protein Dis. 2024 Mar 29;3(1):10.36922/gpd.1966. doi: 10.36922/gpd.1966. Gene Protein Dis. 2024. PMID: 38766604 Free PMC article. - Association between dopamine receptor D2 Taq IA gene polymorphism (rs1800497) and personality traits.
Olasore HSA, Oyedeji TA, Faleti JO, Ogundele OI, Olashore AA. Olasore HSA, et al. SAGE Open Med. 2024 May 14;12:20503121241241922. doi: 10.1177/20503121241241922. eCollection 2024. SAGE Open Med. 2024. PMID: 38751571 Free PMC article. - Association of SLC6A3 variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia.
Kogure M, Kanahara N, Miyazawa A, Shiko Y, Otsuka I, Matsuyama K, Takase M, Kimura M, Kimura H, Ota K, Idemoto K, Tamura M, Oda Y, Yoshida T, Okazaki S, Yamasaki F, Nakata Y, Watanabe Y, Niitsu T, Hishimoto A, Iyo M. Kogure M, et al. Front Psychiatry. 2024 Feb 27;14:1334335. doi: 10.3389/fpsyt.2023.1334335. eCollection 2023. Front Psychiatry. 2024. PMID: 38476817 Free PMC article. - Are We Getting High Cause the Thrill is Gone?
Blum K, Mclaughlin T, Gold MS, Gondre-Lewis MC, Thanos PK, Elman I, Baron D, Bowirrat A, Barh D, Khalsa J, Hanna C, Jafari N, Zeine F, Braverman ER, Dennen C, Makale MT, Makale M, Sunder K, Murphy KT, Badgaiyan RD. Blum K, et al. J Addict Psychiatry. 2023;7(1):5-516. Epub 2023 Dec 8. J Addict Psychiatry. 2023. PMID: 38164471 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources